First Time Loading...

Trevena Inc
NASDAQ:TRVN

Watchlist Manager
Trevena Inc Logo
Trevena Inc
NASDAQ:TRVN
Watchlist
Price: 0.381 USD -1.8% Market Closed
Updated: Apr 25, 2024

Intrinsic Value

TRVN's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. [ Read More ]

The intrinsic value of one TRVN stock under the Base Case scenario is 1.164 USD. Compared to the current market price of 0.381 USD, Trevena Inc is Undervalued by 67%.

Key Points:
TRVN Intrinsic Value
Base Case
1.164 USD
Undervaluation 67%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Trevena Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling TRVN stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Trevena Inc

Provide an overview of the primary business activities
of Trevena Inc.

What unique competitive advantages
does Trevena Inc hold over its rivals?

What risks and challenges
does Trevena Inc face in the near future?

Has there been any significant insider trading activity
in Trevena Inc recently?

Summarize the latest earnings call
of Trevena Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Trevena Inc.

Provide P/S
for Trevena Inc.

Provide P/E
for Trevena Inc.

Provide P/OCF
for Trevena Inc.

Provide P/FCFE
for Trevena Inc.

Provide P/B
for Trevena Inc.

Provide EV/S
for Trevena Inc.

Provide EV/GP
for Trevena Inc.

Provide EV/EBITDA
for Trevena Inc.

Provide EV/EBIT
for Trevena Inc.

Provide EV/OCF
for Trevena Inc.

Provide EV/FCFF
for Trevena Inc.

Provide EV/IC
for Trevena Inc.

Show me price targets
for Trevena Inc made by professional analysts.

What are the Revenue projections
for Trevena Inc?

How accurate were the past Revenue estimates
for Trevena Inc?

What are the Net Income projections
for Trevena Inc?

How accurate were the past Net Income estimates
for Trevena Inc?

What are the EPS projections
for Trevena Inc?

How accurate were the past EPS estimates
for Trevena Inc?

What are the EBIT projections
for Trevena Inc?

How accurate were the past EBIT estimates
for Trevena Inc?

Compare the revenue forecasts
for Trevena Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Trevena Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Trevena Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Trevena Inc compared to its peers.

Compare the P/E ratios
of Trevena Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Trevena Inc with its peers.

Analyze the financial leverage
of Trevena Inc compared to its main competitors.

Show all profitability ratios
for Trevena Inc.

Provide ROE
for Trevena Inc.

Provide ROA
for Trevena Inc.

Provide ROIC
for Trevena Inc.

Provide ROCE
for Trevena Inc.

Provide Gross Margin
for Trevena Inc.

Provide Operating Margin
for Trevena Inc.

Provide Net Margin
for Trevena Inc.

Provide FCF Margin
for Trevena Inc.

Show all solvency ratios
for Trevena Inc.

Provide D/E Ratio
for Trevena Inc.

Provide D/A Ratio
for Trevena Inc.

Provide Interest Coverage Ratio
for Trevena Inc.

Provide Altman Z-Score Ratio
for Trevena Inc.

Provide Quick Ratio
for Trevena Inc.

Provide Current Ratio
for Trevena Inc.

Provide Cash Ratio
for Trevena Inc.

What is the historical Revenue growth
over the last 5 years for Trevena Inc?

What is the historical Net Income growth
over the last 5 years for Trevena Inc?

What is the current Free Cash Flow
of Trevena Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Trevena Inc.

Financials

Balance Sheet Decomposition
Trevena Inc

Current Assets 35.2m
Cash & Short-Term Investments 33m
Other Current Assets 2.2m
Non-Current Assets 5.4m
PP&E 4.9m
Other Non-Current Assets 540k
Current Liabilities 7.6m
Accounts Payable 2.3m
Accrued Liabilities 5.2m
Other Current Liabilities 10k
Non-Current Liabilities 40.7m
Long-Term Debt 30.8m
Other Non-Current Liabilities 9.9m
Efficiency

Earnings Waterfall
Trevena Inc

Revenue
3.1m USD
Cost of Revenue
-1.7m USD
Gross Profit
1.5m USD
Operating Expenses
-36.7m USD
Operating Income
-35.3m USD
Other Expenses
-5m USD
Net Income
-40.3m USD

Free Cash Flow Analysis
Trevena Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

TRVN Profitability Score
Profitability Due Diligence

Trevena Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Negative 1-Year Revenue Growth
Declining ROE
18/100
Profitability
Score

Trevena Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

TRVN Solvency Score
Solvency Due Diligence

Trevena Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Negative Net Debt
Long-Term Solvency
42/100
Solvency
Score

Trevena Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TRVN Price Targets Summary
Trevena Inc

There are no price targets for TRVN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

TRVN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

TRVN Price
Trevena Inc

1M 1M
-12%
6M 6M
-30%
1Y 1Y
-40%
3Y 3Y
-99%
5Y 5Y
-99%
10Y 10Y
-100%
Annual Price Range
0.381
52w Low
0.352
52w High
3.11
Price Metrics
Average Annual Return -14.11%
Standard Deviation of Annual Returns 108.46%
Max Drawdown -100%
Shares Statistics
Market Capitalization 6.6m USD
Shares Outstanding 18 321 000
Percentage of Shares Shorted 0.62%

TRVN Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Trevena Inc Logo
Trevena Inc

Country

United States of America

Industry

Biotechnology

Market Cap

6.6m USD

Dividend Yield

0%

Description

Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. The company is headquartered in Chesterbrook, Pennsylvania and currently employs 43 full-time employees. The company went IPO on 2014-01-31. The firm is focused on developing and commercializing medicines for patients affected by central nervous system (CNS) disorders. The company is developing OLINVYK, a G-protein biased MOR ligand for acute pain in adults. The company is developing TRV027, an angiotensin II type 1 (AT1), receptor selective agonist, for the treatment of acute lung injury contributing to acute respiratory distress syndrome (ARDS), and abnormal blood clotting in patients with COVID-19. The company is developing TRV250, a G-protein biased delta-opioid receptor (DOR), is developed for the treatment of acute migraine. The firm is focused on exploring other formulations, such as transmucosal or transdermal administration for breakthrough or chronic pain, respectively. The firm is in the Phase III clinical program for OLINVO with the enrollment of patients in the ATHENA study, a Phase III, open-label, multicenter study.

Contact

PENNSYLVANIA
Chesterbrook
955 Chesterbrook Blvd Ste 110
+16103548840.0
http://www.trevena.com/

IPO

2014-01-31

Employees

43

Officers

President, CEO & Chairman
Ms. Carrie L. Bourdow
Executive VP, COO & CFO
Mr. Barry Shin
Senior VP & Chief Medical Officer
Dr. Mark A. Demitrack M.D.
Scientific Founder, Consultant and Member of Scientific Advisory Board
Dr. Howard A. Rockman M.D.
VP, General Counsel & Chief Compliance Officer
Mr. Joel Solomon
Vice President of Marketing
Mr. Michael Catalano
Show More
Senior VP, Chief Business Officer & Head of Commercial Operations
Mr. Robert T. Yoder
Senior VP & Chief Commercial Officer
Ms. Patricia M. Drake
Show Less

See Also

Discover More
What is the Intrinsic Value of one TRVN stock?

The intrinsic value of one TRVN stock under the Base Case scenario is 1.164 USD.

Is TRVN stock undervalued or overvalued?

Compared to the current market price of 0.381 USD, Trevena Inc is Undervalued by 67%.